Photo: the panel visiting the new facility at Matfors.
Advanced Biologics in Matfors and Beyond
During a two day conference, a number of key stakeholders from the Swedish and Danish ecosystem visited the Matfors site of NorthX Biologics. The highlight of the tour being the walk about in our GMP licenced facility for ATMP manufacturing as well as the brand new innovation area, delegates also valued the discussions as such. How important it is not least for the government to know we have such capacity on Swedish territory. Yet, from a business perspective of NorthX, the importance to reach beyond the Nordics to showcase how biotechs can use this capacity.
As the conference was such a success, with a waiting list for those that we could not fit, we are already planning for a follow up! Stay tuned.